A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2

por Kim, Soo-Youl, Keillor, Jeffrey W.
Publicado 2020

Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation

por Colak, Gozde, Keillor, Jeffrey W., Johnson, Gail V. W.
Publicado 2011

Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells

por Caron, Nicholas S., Munsie, Lise N., Keillor, Jeffrey W., Truant, Ray
Publicado 2012

Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase

por Oteng-Pabi, Samuel K., Clouthier, Christopher M., Keillor, Jeffrey W.
Publicado 2018

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Tran...

por Jambrovics, Károly, Uray, Iván P., Keillor, Jeffrey W., Fésüs, László, Balajthy, Zoltán
Publicado 2020

Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation

por Tsao, Kelvin K., Lee, Ann C., Racine, Karl É., Keillor, Jeffrey W.
Publicado 2020

Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation

por Jambrovics, Károly, Uray, Iván P., Keresztessy, Zsolt, Keillor, Jeffrey W., Fésüs, László, Balajthy, Zoltán
Publicado 2019

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition

por Fisher, Matthew L., Adhikary, Gautam, Xu, Wen, Kerr, Candace, Keillor, Jeffrey W., Eckert, Richard L.
Publicado 2015

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase

por Gates, Eric W. J., Mansour, Kian, Ebrahimi Samani, Sahar, Shad, Sammir, Kaartinen, Mari T., Keillor, Jeffrey W.
Publicado 2023

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation

por Adhikary, Gautam, Grun, Daniel, Alexander, H. Richard, Friedberg, Joseph S., Xu, Wen, Keillor, Jeffrey W., Kandasamy, Sivaveera, Eckert, Richard L.
Publicado 2018

Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics

por Al-Jallad, Hadil F., Myneni, Vamsee D., Piercy-Kotb, Sarah A., Chabot, Nicolas, Mulani, Amina, Keillor, Jeffrey W., Kaartinen, Mari T.
Publicado 2011

The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2

por Bianchi, Nicoletta, Brugnoli, Federica, Grassilli, Silvia, Bourgeois, Karine, Keillor, Jeffrey W., Bergamini, Carlo M., Aguiari, Gianluca, Volinia, Stefano, Bertagnolo, Valeria
Publicado 2021

Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury

por Elahi, Anissa, Emerson, Jacen, Rudlong, Jacob, Keillor, Jeffrey W., Salois, Garrick, Visca, Adam, Girardi, Peter, Johnson, Gail V.W., Pröschel, Christoph
Publicado 2021

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer

por Aguiari, Gianluca, Crudele, Francesca, Taccioli, Cristian, Minotti, Linda, Corrà, Fabio, Keillor, Jeffrey W., Grassilli, Silvia, Cervellati, Carlo, Volinia, Stefano, Bergamini, Carlo M., Bianchi, Nicoletta
Publicado 2022

A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K(+) Channel in Breast Cancer

por Canella, Rita, Brugnoli, Federica, Gallo, Mariana, Keillor, Jeffrey W., Terrazzan, Anna, Ferrari, Elena, Grassilli, Silvia, Gates, Eric W. J., Volinia, Stefano, Bertagnolo, Valeria, Bianchi, Nicoletta, Bergamini, Carlo M.
Publicado 2022

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype

por Gates, Eric W. J., Calvert, Nicholas D., Cundy, Nicholas J., Brugnoli, Federica, Navals, Pauline, Kirby, Alexia, Bianchi, Nicoletta, Adhikary, Gautam, Shuhendler, Adam J., Eckert, Richard L., Keillor, Jeffrey W.
Publicado 2023

Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival

por Kerr, Candace, Szmacinski, Henryk, Fisher, Matthew L., Nance, Bailey, Lakowicz, Joseph R., Akbar, Abdullah, Keillor, Jeffrey W., Wong, Tin Lok, Godoy-Ruiz, Raquel, Toth, Eric A., Weber, David J., Eckert, Richard L.
Publicado 2016

Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid

por Qin, Xian-Yang, Furutani, Yutaka, Yonezawa, Kento, Shimizu, Nobutaka, Kato-Murayama, Miyuki, Shirouzu, Mikako, Xu, Yali, Yamano, Yumiko, Wada, Akimori, Gailhouste, Luc, Shrestha, Rajan, Takahashi, Masataka, Keillor, Jeffrey W., Su, Ting, Yu, Wenkui, Fujii, Shinya, Kagechika, Hiroyuki, Dohmae, Naoshi, Shirakami, Yohei, Shimizu, Masahito, Masaki, Takahiro, Matsuura, Tomokazu, Suzuki, Harukazu, Kojima, Soichi
Publicado 2023